FIELD: genetic engineering, molecular biology. SUBSTANCE: invention relates to vectors comprising defective viral genome that expresses antigen useful for induction of secretory and systemic immune responses and antibody providing protection against infectious agent. The presented defective viral genome is prepared from the parental genome of porcine virus of transmissive gastroenteritis (TGEV) by deleting part of parental genome and retains 3'- and 5'-ends of parental genome with localized recognition signals by viral replicase and at least a promoter. Indicated vectors are useful for design of recombinant system that comprises the indicated expression vector and helper virus. Such system is used for preparing mono- and polyvalent vaccines against infectious agents of animals of different species. Invention proposes also vectors of expression of heterologous genes with high level of safety and capacity of cloning and their construction provides species specificity and tropism that can be controlled easily. EFFECT: valuable properties of vector. 14 cl, 2 tbl, 30 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
NORTH AMERICAN PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) VIRUS AND USES THEREOF | 2011 |
|
RU2592667C2 |
RECOMBINANT VACCINE OF INACTIVATED VIRAL VECTOR | 2008 |
|
RU2528750C2 |
SIMIAN ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USE THEREOF | 2010 |
|
RU2604815C2 |
RAPID SELECTION METHOD FOR HIV GP-120 VARIANTS | 2012 |
|
RU2603732C2 |
COMPOSITION BASED ON LELISTAD FACTOR (VARIANTS), VACCINE (VARIANTS), DIAGNOSTIC SET (VARIANTS) AND METHOD OF DIAGNOSIS | 1992 |
|
RU2124051C1 |
FLAVIVIRUS WITH BIPARTITE GENOME AND USING IT | 2008 |
|
RU2527891C2 |
RECOMBINANT CLASSICAL SWINE FEVER VIRUS (CSFV), WHICH CONTAINS MODIFIED PROTEIN E2, AND CREATION METHODS OF ABOVE DESCRIBED RECOMBINANT CSFV | 2009 |
|
RU2501854C2 |
IMMUNOGENIC COMPOSITIONS FOR IMMUNIZATION OF PIGS AGAINST CIRCOVIRUS TYPE 3 AND METHODS OF PRDUCTION AND APPLICATION THEREOF | 2016 |
|
RU2744193C2 |
SYSTEMS FOR EXPRESSION OF NEWCASTLE DISEASE VIRUS RECOMBINANT RNA AND VACCINES | 1999 |
|
RU2270864C2 |
PAPILLOMAVIRUS E2 POLYPEPTIDES USED FOR VACCINATION | 2008 |
|
RU2482189C2 |
Authors
Dates
2003-02-27—Published
1997-03-12—Filed